Efficacy of antibacterial drugs in mice with complex infection by Candida albicans and Escherichia coli

Journal of Antibiotics

Volumn 52, Issue 6, 1999, Pages 552-558

  Ikeda, Tatsuo ^a   Suegara, Nobuo ^a   Abe, Shigeru ^a   Yamaguchi, Hideyo ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; AMPICILLIN; ANTIINFECTIVE AGENT; CEFOTAXIME; GENTAMICIN; KANAMYCIN; MINOCYCLINE; PIPERACILLIN; TETRACYCLINE; TETRACYCLINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COUNT; CANDIDA ALBICANS; CONTROLLED STUDY; DRUG EFFICACY; ESCHERICHIA COLI; EXPERIMENTAL INFECTION; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; KIDNEY; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUPERINFECTION; SURVIVAL;

EID: 0032818032     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.7164/antibiotics.52.552     Document Type: Article

References (13)

1. BAKALETZ, L. O.: Viral potentiation of bacterial superinfection the respiratory tract. Trends in Microbiology 3: 110-114, 1995
2. BILLETER, M.: Rationale and experience in treating suspected hospital based mixed infections. Pharmacotherapy 15 (1pt 2): 22S-26S, 1995
3. DIPIRO, J. T.: Considerations for therapy of mixed infections: Focus on intraabdominal infection. Pharmacotherapy 15 (1 pt 2): 15S-21S, 1995
4. DYESS, D. L.; R. N. GARRISON & D. E. FRY: Candida sepsis : Implications of polymicrobial blood-borne infection. Arch. Surg. 120: 345-348, 1985
5. SAUNDERS, G. L.; J. M. J. HAMMOND, P. D. POTGIETER, H. A. PLUMB & A. A. FORDER: Microbiological surveillance during selective decontamination of the digestive tract. J. Antimicrob. Chemother. 34: 529-544, 1994
6. STOUTENBEEK, C. P.; H. K. F. VAN SAENE, D. R. MIRANDA, D. F. ZANDSTRA & B. BINNENDIJIK: The prevention of superinfection in multiple trauma patients. J. Antimicrob. Chemother. 14 (Suppl. B): 203-211, 1984
7. BURD, R. S.; C. S. RAYMOND & D. L. DUNN: Endotoxin promotes synergistic lethality during concurrent Escherichia coli and Candida albicans infection. J. Surg. Res. 52: 537-542, 1992
8. AKAGAWA, G.; S. ABE & H. YAMAGUCHI: Mortality of Candida albicans-infected mice is facilitated by superinfection of Escherichia coli or administration of its lipopolysaccharide. J. Infect. Dis. 171: 1539-1544, 1995
9. KERR, J.: Inhibition of fungal growth by Pseudomonas aeruginosa and Pseudomonas cepacia isolated from patients with cystic fibrosis. J. Infect. 28: 305-310, 1994
10. SHENEP, J. L. & K. A. MOGAN: Kinetics of endotoxin release during antibiotic therapy for experimental Gram-negative bacterial sepsis. J. Infect. Dis. 150: 380-388, 1984
11. SHENEP, J. L.; R. P. BARTON & K. A. MOGAN: Role of antibiotic class in the rate of liberation of endotoxin during therapy for experimental Gram-negative bacterial sepsis. J. Infect. Dis. 151: 1012-1018, 1985
12. GOTO, H. & S. NAKAMURA: Liberation of endotoxin from Escherichia coli by addition of antibiotics. Japan J. Exp. Med. 50: 35-41, 1980
13. WEINSTEIN, M. P.; M. L. TOWNS, S. M. QUARTEY, S. MIRRETT, L. G. REIMER, G. PARMIGIANI & L. B. RELLER: The clinical significance of postive blood cultures in the 1990s: A prospective comprehensive evalution of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin. Infect. Dis. 24: 584-602, 1997